ArticleJournal for immunotherapy of cancer2021

CD137 and PD-L1 targeting with immunovirotherapy induces a potent and durable antitumor immune response in glioblastoma models.

Montserrat Puigdelloses et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.